FBLN1 and chronic obstructive pulmonary disease: The genetic inhibition of FBLN1 decreases the inflammatory cells by reducing pro-inflammatory cytokines within chronic obstructive pulmonary disease (Liu et al., 2016) and its expression increases infiltrating macrophages by elevating the stromal and immune scores in high FBLN1 tissues (Gong et al., 2020).